233 related articles for article (PubMed ID: 18802956)
1. Gastric cancer histology: clinicopathologic characteristics and prognostic value.
Park JM; Jang YJ; Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS
J Surg Oncol; 2008 Dec; 98(7):520-5. PubMed ID: 18802956
[TBL] [Abstract][Full Text] [Related]
2. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
3. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer.
Kim BS; Oh ST; Yook JH; Kim BS
Surgery; 2014 Jun; 155(6):1030-5. PubMed ID: 24792508
[TBL] [Abstract][Full Text] [Related]
4. Indication for endoscopic mucosal resection in early signet ring cell gastric cancer.
Ha TK; An JY; Youn HK; Noh JH; Sohn TS; Kim S
Ann Surg Oncol; 2008 Feb; 15(2):508-13. PubMed ID: 18071825
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
7. Progression and prognosis of gastric stump cancer.
Hu X; Tian DY; Cao L; Yu Y
J Surg Oncol; 2009 Nov; 100(6):472-6. PubMed ID: 19697396
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma.
Zhang M; Zhu GY; Zhang HF; Gao HY; Han XF; Xue YW
J Surg Oncol; 2010 Jul; 102(1):64-7. PubMed ID: 20578080
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological study of mucinous gastric carcinoma.
Shibuya H; Nishida R; Koide S; Kurokawa J; Okita K
Ann Chir Gynaecol; 2000; 89(4):273-6. PubMed ID: 11204957
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
[TBL] [Abstract][Full Text] [Related]
11. Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival.
Rohatgi PR; Yao JC; Hess K; Schnirer I; Rashid A; Mansfield PF; Pisters PW; Ajani JA
Cancer; 2006 Dec; 107(11):2576-80. PubMed ID: 17075877
[TBL] [Abstract][Full Text] [Related]
12. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic strategy for signet ring cell carcinoma of the stomach.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Akiyama H
Br J Surg; 2004 Oct; 91(10):1319-24. PubMed ID: 15376179
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma.
Otsuji E; Yamaguchi T; Sawai K; Hagiwara A; Taniguchi H; Takahashi T
Cancer; 1998 Apr; 82(7):1233-7. PubMed ID: 9529013
[TBL] [Abstract][Full Text] [Related]
15. Mucin-producing gastric cancer: clinicopathological difference between signet ring cell carcinoma and mucinous carcinoma.
Fang WL; Wu CW; Lo SS; Chen JH; Hsieh MC; Shen KH; Li AF; Tai LC; Lui WY
Hepatogastroenterology; 2009; 56(93):1227-31. PubMed ID: 19760976
[TBL] [Abstract][Full Text] [Related]
16. Advanced gastric carcinoma with signet ring cell histology.
Li C; Kim S; Lai JF; Hyung WJ; Choi WH; Choi SH; Noh SH
Oncology; 2007; 72(1-2):64-8. PubMed ID: 18004078
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic resection for undifferentiated early gastric cancer.
Kim JH; Lee YC; Kim H; Song KH; Lee SK; Cheon JH; Kim H; Hyung WJ; Noh SH; Kim CB; Chung JB
Gastrointest Endosc; 2009 Apr; 69(4):e1-9. PubMed ID: 19327466
[TBL] [Abstract][Full Text] [Related]
18. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
19. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N
Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813
[TBL] [Abstract][Full Text] [Related]
20. Tumor size: a non-neglectable independent prognostic factor for gastric cancer.
Wang X; Wan F; Pan J; Yu GZ; Chen Y; Wang JJ
J Surg Oncol; 2008 Mar; 97(3):236-40. PubMed ID: 18095266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
